For decades, Parkinson’s disease has been framed as a simple story of dwindling dopamine, a slow erosion of the brain’s ...

The HealthWell Foundation funded Brukinsa (zanubrutinib) for Mike, enabling him to afford the treatment and maintain his ...

Prescription stimulants, such as Ritalin and Adderall, are widely used to treat attention deficit hyperactivity disorder (ADHD), including in children. In the U.S., about 3.5 million children aged 3 ...

A 67-year-old says a new £2,000 device, which is being studied by the NHS, has improved his sleep and allowed him to go back ...

MALVERN, PA — Annovis Bio, Inc. (NYSE: ANVS) said it will begin enrolling patients in January 2026 in a large, long-term study designed to assess whether its experimental Parkinson’s disease ...

Health professionals and community members recently gathered at the University of Arkansas for Medical Sciences (UAMS) Donald ...

Historically, people with amyotrophic lateral sclerosis (ALS) experience a relentless decline in neurological function that ...

We do know Parkinson's is caused by the loss of dopamine nerve cells in the part of the brain responsible for voluntary ...

IPX203 is a novel, oral modified-release formulation of LD/CD designed for the treatment of Parkinson’s disease, the fastest growing neurological condition in the world according to the World Health ...

A new study shows dopamine isn’t the brain’s movement “gas pedal” after all. Instead of setting speed or strength, it quietly ...

AIIMS Delhi held India's first workshop on Deep Brain Stimulation (DBS) for Parkinson’s. Experts trained 200+ clinicians in advanced surgery and programming to improve patient care and debunk myths.